Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Doximity, Inc. Class A

Stage 2 · Advancing · week 2

As of Oct 22, 2026, Doximity is in Stage 2, the uptrend phase, now in week 2 (since Oct 14, 2026). It closed at $33.68, 50.8% below its 52-week high and above its 200-day average, which is falling.

Doximity, Inc. operates a digital platform for medical professionals in the United States. More about the company

$33.68
-0.03% today
$6.0B · Mid cap
Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 16 in Health Information Services · #1 of 272 in Health Care

Is DOCS early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 15w
S2 45w
S2 19w
S4 35w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 15w → S1 11w → S2 6w → S3 11w → S2 45w → S3 10w → S2 19w → S3 3w → S4 35w → S1 9w → S2 1w current
Total tracked: 166 weeks across 11 stage runs.

DOCS among Health Information Services27th of 41 by relative strength

All 41 →
Stocks in Health Information Services ranked by relative strength, with stage and one-month change
#StockStageRS1M
1AMWLStage 2 · wk 2597+7.4%
2HNGEStage 2 · wk 2096+19.1%
3BTSGStage 3 · wk 894+9.1%
4NRCStage 3 · wk 493−0.1%
5SOPHStage 2 · wk 2491−12.7%
6HTFLStage 2 · wk 1087+17.0%
7HSTMStage 2 · wk 1777+20.3%
8OMCLStage 4 · wk 1070+12.5%
…27DOCSStage 2 · wk 223+26.8%
vs 52W High
-50.8%
$18.01 lo$68.50 hi
50.8% below 52W high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 2
1w13w26w
Week 2, fresh breakout
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
30.3%
200 DMA: $25.85 · sloping down
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
0.93x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↑
Short-term trend rising strongly
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+26.8%
3M
+64.9%
6M
+45.4%
YTD
-22.2%
1Y
-50.4%
Scan Membership
Breakout Watch
Latest: 2024-06-12
5 appearances in last 60 days. First seen: 2023-02-08.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 2 · Vol 0.93x
2026-10-21S2
Wk 2 · Vol 0.69x
2026-10-20S2
Wk 1 · Vol 1.34x
2026-10-19S2
Wk 1 · Vol 0.45x
2026-10-16S2
Wk 1 · Vol 0.73x
2026-10-15S2
Wk 1 · Vol 0.64x
2026-10-14S21→2
Wk 1 · Vol 0.55x
2026-10-13S1
Wk 9 · Vol 0.60x
2026-10-12S1
Wk 9 · Vol 0.69x
2026-10-09S1
Wk 9 · Vol 1.01x
2026-10-08S1
Wk 8 · Vol 1.07x
2026-10-07S1
Wk 8 · Vol 0.49x
Moving averages & range
50 DMA
$27.34
200 DMA
$25.85
52W High
$68.50
52W Low
$18.01
5D Low
$30.97
Resistance levels (recent highs)
20d High
$33.69
60d High
$33.69
120d High
$33.69
250d High
$68.50
Next resistance
+0.0%
to 20d High
P/E (TTM)
39.6
Forward 21.6
Earnings Growth (YoY)
-51.9%
Revenue +7.3%
ROE
+17.2%
Profit margin +25.5%
Dividend Yield
0.00%
P/B 6.6

Doximity: quick answers

What stage is Doximity in?

As of Oct 22, 2026, Doximity (DOCS) is in Stage 2, the uptrend phase. It entered Stage 2 on Oct 14, 2026 and is in week 2. What the four stages mean

Is Doximity in an uptrend?

Yes. Doximity is in a Stage 2 uptrend. It trades 30.3% above its 200-day average, which is falling.

How far is Doximity from its 52-week high?

Doximity closed at $33.68 on Oct 22, 2026, 50.8% below its 52-week high of $68.50. Its 52-week low is $18.01.

How has Doximity performed over the past year?

As of Oct 22, 2026, Doximity is down 50.4% over the past year and down 22.2% so far in 2026.

Which sector and industry is Doximity in?

Doximity is in the Health Information Services industry, part of the Health Care sector.

About this companyHealth Care· Health Information Services

Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.